Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor

Patel, Smita, Freedman, Stephen, Chapman, Kerry L., Emms, Frances, Fletcher, Alan E., Knowles, Mick, Marwood, Rosemarie, Mcallister, George, Myers, Jan, Patel, Shil, Curtis, Neil, Kulagowski, Jan J., Leeson, Paul D., Ridgill, Mark, Graham, Mike, Matheson, Steve, Rathbone, Denise, Watt, Alan P., Bristow, Linda J., Rupniak, Nadia M.J., Baskin, Elizabeth, Lynch, Joseph J., Ragan, C. Ian · 1997 · The Journal of Pharmacology and Experimental Therapeutics

Abstract

L-745,870,(3-([4-(4-chlorophenyl)piperazin-1-yl]methyl)-1H- pyrollo[2,3-b] pyridine, was identified as a selective dopamine D4 receptor antagonist with excellent oral bioavailability and brain penetration. L-745,870 displaced specific binding of 0.2 nM [3H] spiperone to cloned human dopamine D4 receptors with a binding affinity (Ki) of 0. 43 nM which was 5- and 20-fold higher than that of the standard antipsychotics haloperidol and clozapine, respectively. L-745,870 exhibited high selectivity for the dopamine D4 receptor (>2000 fold) compared to other dopamine receptor subtypes and had moderate affinity for 5HT2, sigma and alpha adrenergic receptors(IC50 < 300 nM). In vitro, L-745,870 (0.1-1 microM) exhibited D4 receptor antagonist activity, reversing dopamine (1 microM) mediated 1) inhibition of adenylate cyclase in hD4HEK and hD4CHO cells; 2) stimulation of [35S] GTPgammaS binding and 3) stimulation of extracellular acidification rate, but did not exhibit any significant intrinsic activity in these assays. Although standard antipsychotics increase dopamine metabolism or plasma prolactin levels in rodents, L-745,870 (</=30 mg/kg p.o.) had no effect in these assays. The lack of a suitable in vivo assay for D4 receptor activation prompted the use of in vivo surrogate marker assays which confirmed that doses of 5-60 microg/kg L-745,870 would be sufficient to occupy 50% D4 receptors in the brain. These results show that dopamine D4 receptor antagonism in the brain does not result in the same neurochemical consequences (increased dopamine metabolism or hyperprolactinemia) observed with typical neuroleptics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(24)37092-2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
Patel, S., Freedman, S., Chapman, K. L., Emms, F., Fletcher, A. E., Knowles, M., Marwood, R., Mcallister, G., Myers, J., Patel, S., Curtis, N., Kulagowski, J. J., Leeson, P. D., Ridgill, M., Graham, M., Matheson, S., Rathbone, D., Watt, A. P., Bristow, L. J., Rupniak, N. M. J., Baskin, E., Lynch, J. J., & Ragan, C. I.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1997-11
Volume
283
Issue
2
Pages
636-647
ISSN
0022-3565 (ISSN-L)
OpenAlex
W1916318562
Cited by
161
References
1
FWCI
3.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor. https://app.cochat.ai/papers/10.1016/s0022-3565(24)37092-2
The paper
Patel, S., Freedman, S., Chapman, K. L., Emms, F., Fletcher, A. E., Knowles, M., Marwood, R., Mcallister, G., Myers, J., Patel, S., Curtis, N., Kulagowski, J. J., Leeson, P. D., Ridgill, M., Graham, M., Matheson, S., Rathbone, D., Watt, A. P., Bristow, L. J., . . . Ragan, C. I. (1997). Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)37092-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.